Metastatic prostate cancer: Abiraterone tied to worse cardiovascular outcomesSeptember 18, 2021Prostate Cancer
High-risk prostate cancer: Persistent PSA after surgery linked to worse outcomesSeptember 18, 2021Prostate Cancer
Prostate cancer: Exercise during active surveillance improves cardiorespiratory fitnessSeptember 18, 2021Prostate Cancer
MRI with PSMA-PET lowers false negatives for clinically significant prostate cancerSeptember 18, 2021Prostate Cancer
Avelumab with SBRT shows good response in castration-resistant prostate cancerSeptember 18, 2021Prostate Cancer
Prostate cancer: Cardiovascular safety of hormone therapies remains unresolvedSeptember 18, 2021Prostate Cancer
Localized prostate cancer: No OS benefit beyond 15 years with added short-term ADTSeptember 18, 2021Prostate Cancer
Prostate cancer: Patient-reported outcomes support hypofractionated radiotherapySeptember 18, 2021Prostate Cancer
Positive cytokeratin 19 expression promotes poor outcomes in HCCSeptember 18, 2021Hepatocellular Carcinoma
Treatment-related adverse events correlate with improved outcomes in HCC patients on immune checkpoint inhibitor therapySeptember 18, 2021Hepatocellular Carcinoma
